<DOC>
	<DOCNO>NCT00160160</DOCNO>
	<brief_summary>This study demonstrate superiority combination eprosartan/HCTZ versus ramipril/HCTZ .</brief_summary>
	<brief_title>Comparison Eprosartan/HCT Versus Enalapril/HCT Hypertensives With Type II Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Eprosartan</mesh_term>
	<criteria>essential hypertension , diabetes type 2 severe cardiovascular disease , grade 3 hypertension , secondary hypertension , abnormal liver enzyme</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>comparator trial</keyword>
	<keyword>hypertension</keyword>
	<keyword>diabetes</keyword>
	<keyword>blood pressure</keyword>
</DOC>